AIM
AIM ImmunoTech
15 hedge funds and large institutions have $294K invested in AIM ImmunoTech in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.96% more ownership
Funds ownership: 0% → 3.96% (+4%)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$119K | |
| 2 | +$79.1K | |
| 3 | +$48K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$44.3K |
| 5 |
Morgan Stanley
New York
|
+$277 |
